RB
CNTB

Richmond Brothers’s Connect Biopharma Holdings CNTB Stock Holding History

Richmond Brothers’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
476,584
+303,099
+175% +$790K 0.83% 22
2025
Q4 		$489K Buy
+173,485
New +$370K 0.31% 27

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Richmond Brothers's CNTB Position: Q1 2026 in Review

Richmond Brothers increased its Connect Biopharma Holdings (CNTB) stake by 175% in Q1 2026, buying an estimated $790K and bringing the position to 476,584 shares worth $1.25M. The position accounts for 0.83% of the portfolio, ranked #22.

Richmond Brothers first reported a position in CNTB in Q4 2025 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Richmond Brothers held 476,584 shares of Connect Biopharma Holdings worth $1.25M as of Q1 2026.
  • Richmond Brothers bought 303,099 Connect Biopharma Holdings shares in Q1 2026, an estimated $790K.
  • Connect Biopharma Holdings made up 0.83% of Richmond Brothers's portfolio in Q1 2026, its #22 holding.
  • Richmond Brothers first reported a position in Connect Biopharma Holdings in Q4 2025 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Richmond Brothers's 13F filing for Q1 2026, filed 11 May 2026.